|
Name |
(3S,3aR,4S,6S,6aR,7E,10S,11E,13R,14S,15Z,17aR)-6,13,14-trihydroxy-3-(1H-indol-3-ylmethyl)-4,10,12-trimethyl-5-methylidene-3,3a,4,5,6,6a,9,10,13,14-decahydro-1H-cyclotrideca[d]isoindole-1,17(2H)-dione
|
Molecular Formula | C32H38N2O5 | |
IUPAC Name* |
(1R,3Z,5S,6R,7E,9S,11E,13R,14S,16S,17R,18S)-5,6,14-trihydroxy-18-(1H-indol-3-ylmethyl)-7,9,16-trimethyl-15-methylidene-19-azatricyclo[11.7.0.01,17]icosa-3,7,11-triene-2,20-dione
|
|
SMILES |
C[C@H]\1C/C=C/[C@H]2[C@@H](C(=C)[C@H]([C@@H]3[C@@]2(C(=O)/C=C\[C@@H]([C@@H](/C(=C1)/C)O)O)C(=O)N[C@H]3CC4=CNC5=CC=CC=C54)C)O
|
|
InChI |
InChI=1S/C32H38N2O5/c1-17-8-7-10-23-30(38)20(4)19(3)28-25(15-21-16-33-24-11-6-5-9-22(21)24)34-31(39)32(23,28)27(36)13-12-26(35)29(37)18(2)14-17/h5-7,9-14,16-17,19,23,25-26,28-30,33,35,37-38H,4,8,15H2,1-3H3,(H,34,39)/b10-7+,13-12-,18-14+/t17-,19+,23-,25-,26-,28-,29+,30+,32+/m0/s1
|
|
InChIKey |
YUFTVRUFJJDEHE-DVBXYZRSSA-N
|
|
Synonyms |
Cytoglobosin B; CHEBI:68815; Q27137193; (3S,3aR,4S,6S,6aR,7E,10S,11E,13R,14S,15Z,17aR)-6,13,14-trihydroxy-3-(1H-indol-3-ylmethyl)-4,10,12-trimethyl-5-methylidene-3,3a,4,5,6,6a,9,10,13,14-decahydro-1H-cyclotrideca[d]isoindole-1,17(2H)-dione
|
|
CAS | NA | |
PubChem CID | 71768062 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 530.7 | ALogp: | 2.6 |
HBD: | 5 | HBA: | 5 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 123.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 39 | QED Weighted: | 0.295 |
Caco-2 Permeability: | -5.005 | MDCK Permeability: | 0.00001040 |
Pgp-inhibitor: | 0.264 | Pgp-substrate: | 0.841 |
Human Intestinal Absorption (HIA): | 0.022 | 20% Bioavailability (F20%): | 0.021 |
30% Bioavailability (F30%): | 0.004 |
Blood-Brain-Barrier Penetration (BBB): | 0.653 | Plasma Protein Binding (PPB): | 92.37% |
Volume Distribution (VD): | 0.411 | Fu: | 5.24% |
CYP1A2-inhibitor: | 0.071 | CYP1A2-substrate: | 0.29 |
CYP2C19-inhibitor: | 0.7 | CYP2C19-substrate: | 0.606 |
CYP2C9-inhibitor: | 0.653 | CYP2C9-substrate: | 0.664 |
CYP2D6-inhibitor: | 0.1 | CYP2D6-substrate: | 0.241 |
CYP3A4-inhibitor: | 0.953 | CYP3A4-substrate: | 0.245 |
Clearance (CL): | 8.175 | Half-life (T1/2): | 0.29 |
hERG Blockers: | 0.139 | Human Hepatotoxicity (H-HT): | 0.519 |
Drug-inuced Liver Injury (DILI): | 0.309 | AMES Toxicity: | 0.03 |
Rat Oral Acute Toxicity: | 0.918 | Maximum Recommended Daily Dose: | 0.961 |
Skin Sensitization: | 0.281 | Carcinogencity: | 0.225 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
Respiratory Toxicity: | 0.978 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002440 | 0.815 | D02DMQ | 0.248 | ||||
ENC002682 | 0.800 | D01TSI | 0.242 | ||||
ENC002955 | 0.785 | D0W7WC | 0.240 | ||||
ENC002679 | 0.783 | D05EJG | 0.240 | ||||
ENC002681 | 0.728 | D0BV3J | 0.240 | ||||
ENC004447 | 0.701 | D0SP3D | 0.236 | ||||
ENC002120 | 0.677 | D09NNH | 0.236 | ||||
ENC002442 | 0.662 | D0V3ZA | 0.235 | ||||
ENC005215 | 0.646 | D02XIY | 0.223 | ||||
ENC004473 | 0.644 | D00YLW | 0.219 |